Zhejiang Palo Alto Pharmaceuticals, Inc.
3 clinical trials · Sponsor
◉ Watch Zhejiang Palo Alto Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate the Safety, Tolerance, Pharmacokinetics Characteristics of PA3670 Tablets in Chinese Healthy Subjects (NCT05851261) | Zhejiang Palo Alto Pharmaceuticals, Inc. | 2023-04-13 |
| Study of the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics of PA1010 in HBV Patients (NCT05019040) | Zhejiang Palo Alto Pharmaceuticals, Inc. | 2021-09-17 |
| Study of the Safety, Tolerability, Pharmacokinetic Characteristics of PA1010 in Healthy Subjects (NCT05468060) | Zhejiang Palo Alto Pharmaceuticals, Inc. | 2020-06-28 |
Track Zhejiang Palo Alto Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.